Single-session attention training for Functional Cognitive Disorder
Feasibility Pilot Study of a Brief Intervention in Functional Cognitive Disorder
This project will try a single-session attention-training intervention to see if it helps adults with Functional Cognitive Disorder have fewer symptoms and better daily functioning.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | King's College Hospital NHS Trust Academic / other |
| Locations | 1 site (London) |
| Trial ID | NCT07379723 on ClinicalTrials.gov |
What this trial studies
Adults meeting criteria for Functional Cognitive Disorder complete baseline questionnaires on cognitive concerns, mood, functional impairment, and quality of life, then attend a single clinic session to learn and practice the Attention Training Technique (ATT). Two scheduled telephone follow-ups collect the same questionnaires plus feedback about the intervention and study experience. The protocol is a feasibility pilot focused on acceptability, adherence, and preliminary signals of change in symptoms and function. Eligibility requires age 65 or below, a normal MRI, no neurological diagnosis, and capacity to consent.
Who should consider this trial
Good fit: Adults aged 65 or younger with a clinical diagnosis of Functional Cognitive Disorder, normal MRI results, no neurological diagnosis, capacity to consent, and not enrolled in another intervention trial are ideal candidates.
Not a fit: People over 65, those with abnormal MRI or a neurological diagnosis, those with severe depression or lacking capacity to consent, and participants already in other intervention trials are unlikely to benefit from this protocol.
Why it matters
Potential benefit: If successful, patients might experience reduced cognitive complaints and improved day-to-day functioning and quality of life after a brief, easily delivered intervention.
How similar studies have performed: Attention Training has shown promise in related conditions such as anxiety and functional neurological symptoms, but its use as a single-session intervention specifically for FCD is largely untested and exploratory.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 65 or below * Meet criteria for diagnosis of FCD (criteria include normal MRI results with no neurological diagnosis, and symptoms that are not explained by any other medical condition, performance at routine pre-baseline neuropsychological assessment within the service) * Not taking part in any other intervention study or trial Exclusion Criteria: * Aged above 65 years * Lack capacity to consent * MRI results not in normal range * Neurological diagnosis * Indication of severe low mood or depression (from clinical interview, routine measures) * Taking part in any other intervention study or trial
Where this trial is running
London
- King's College Hospital — London, United Kingdom (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.